Literature DB >> 10913673

Interphase FISH for Y chromosome, VNTR polymorphisms, and RT-PCR for BCR-ABL in the monitoring of HLA-matched and mismatched transplants.

B Crescenzi1, M Fizzotti, S Piattoni, R La Starza, C Matteucci, A Carotti, F Aversa, M F Martelli, C Mecucci.   

Abstract

Thirty-six sex-mismatched transplants were studied using fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) methods. Molecular cytogenetics was performed using interphase FISH with a centromeric probe for chromosome Y, and PCR amplification was performed with a set of VNTR microsatellite loci. In addition, reverse transcriptase-PCR (RT-PCR) for BCR-ABL fusion was used to investigate cases of Philadelphia chromosome (Ph)-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Our integrated approach of post-transplant monitoring was helpful in documenting successful transplants and in controlling the size of Ph-positive clones in CML. A striking overlap was found between results from FISH analysis and PCR for polymorphic loci.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913673     DOI: 10.1016/s0165-4608(99)00245-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemia.

Authors:  Giovanni Roti; Roberto Rosati; Rossella Bonasso; Paolo Gorello; Daniela Diverio; Massimo Fabrizio Martelli; Brunangelo Falini; Cristina Mecucci
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

2.  Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin.

Authors:  Albert C Yeh; Paul V O'Donnell; Gary Schoch; Paul J Martin; Chris McFarland; Jeannine S McCune; Jason P Cooper; Kris Doney; Mary E D Flowers; Mohamed L Sorror; Frederick R Appelbaum; Barry E Storer; Ted Gooley; H Joachim Deeg
Journal:  Bone Marrow Transplant       Date:  2021-11-05       Impact factor: 5.174

3.  Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.

Authors:  R A Brodsky; L Luznik; J Bolaños-Meade; M S Leffell; R J Jones; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-07-14       Impact factor: 5.483

4.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

5.  FLT3 and NPM-1 mutations in a cohort of acute promyelocytic leukemia patients from India.

Authors:  Suchitra Swaminathan; Swati Garg; Manisha Madkaikar; Maya Gupta; Farah Jijina; Kanjaksha Ghosh
Journal:  Indian J Hum Genet       Date:  2014-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.